Skip to search formSkip to main contentSkip to account menu

mepindolol

Known as: 1-(Isopropylamino)-3-((2-methylindol-4-yl)oxy)-2-propanol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
In the present study the beta-adrenoreceptor blocking effects of acute and repeated transdermally delivered mepindolol (20 mg/9.8… 
1988
1988
After improvement of technical equipment continuous ambulatory blood pressure monitoring is more and more used in the diagnosis… 
1988
1988
SummaryAfter improvement of technical equipment continuous ambulatory blood pressure monitoring is more and more used in the… 
1985
1985
The splanchnic and systemic haemodynamic effects of mepindolol (0.6 mg, IV), a beta-blocker with a marked beta 2-blockade… 
1985
1985
Summary: Mepindolol is a newly developed β-adrenergic blocking agent reported to counteract the chronotropic effect of… 
1985
1985
SummaryAbrupt withdrawal of β-adrenoceptor antagonists may lead to “rebound-effects”. To study the mechanism underlying this… 
1978
1978
In a controlled double-blind crossover trial of 5 mg mepindolol versus 80 mg propranolol, 15 mg pindolol or placebo given as… 
1978
1978
The haemodynamic effects of a β-receptor blockade with mepindolol-sulphate and propranolol were studied under basal conditions…